In the USA, it is unknown whether metastatic prostate cancer incidence has continued to increase and whether racial differences have persisted.
Combining multiple imputation with age and delay adjustment, we provide an up-to-date, comprehensive assessment of US prostate cancer incidence trends by stage and race.